Correlation Between Atresmedia Corporacin and Vytrus Biotech

Can any of the company-specific risk be diversified away by investing in both Atresmedia Corporacin and Vytrus Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atresmedia Corporacin and Vytrus Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Atresmedia Corporacin de and Vytrus Biotech SA, you can compare the effects of market volatilities on Atresmedia Corporacin and Vytrus Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atresmedia Corporacin with a short position of Vytrus Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atresmedia Corporacin and Vytrus Biotech.

Diversification Opportunities for Atresmedia Corporacin and Vytrus Biotech

0.31

Correlation Coefficient

Atresmedia Corporacin  Vytrus Biotech

Weak diversification

The 3 months correlation between Atresmedia and Vytrus is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Atresmedia Corporacin de and Vytrus Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vytrus Biotech SA and Atresmedia Corporacin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atresmedia Corporacin de are associated (or correlated) with Vytrus Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vytrus Biotech SA has no effect on the direction of Atresmedia Corporacin i.e., Atresmedia Corporacin and Vytrus Biotech go up and down completely randomly.

Pair Corralation between Atresmedia Corporacin and Vytrus Biotech

Assuming the 90 days trading horizon Atresmedia Corporacin de is expected to generate 0.19 times more return on investment than Vytrus Biotech. However, Atresmedia Corporacin de is 5.14 times less risky than Vytrus Biotech. It trades about 0.08 of its potential returns per unit of risk. Vytrus Biotech SA is currently generating about 0.01 per unit of risk. If you would invest  288.00  in Atresmedia Corporacin de on October 21, 2024 and sell it today you would earn a total of  152.00  from holding Atresmedia Corporacin de or generate 52.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	94.25%
Values	Daily Returns

Atresmedia Corporacin de  vs.  Vytrus Biotech SA

Atresmedia Corporacin

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Atresmedia Corporacin de has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Atresmedia Corporacin is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Vytrus Biotech SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Vytrus Biotech is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Atresmedia Corporacin and Vytrus Biotech

The main advantage of trading using opposite Atresmedia Corporacin and Vytrus Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atresmedia Corporacin position performs unexpectedly, Vytrus Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vytrus Biotech will offset losses from the drop in Vytrus Biotech's long position.

The idea behind Atresmedia Corporacin de and Vytrus Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.